Colon Cancer Cells Evade Drug Action by Enhancing Drug Metabolism
B. Cong, T. Thakur, A. H. Uribe, E. Stamou, S. Gopinath, O. Maddocks, R. Cagan
The paper identifies glucuronidation pathway upregulation as a mechanism by which colon cancer cells develop resistance to trametinib, showing that inhibiting this pathway can reverse resistance in both Drosophila and mouse models.
bioRxiv · Dec 21, 2023Cancer Biology